Kerala High Court Orders Reports on Ribociclib-Palbociclib Substitution by August 21
GS2Polity · Governance · IR· Health policy & public health· Prelims + Mains·
Why in news
The Kerala High Court sought expert reports from national cancer institutes and the DCGI on the interchangeability of Ribociclib and Palbociclib to address high costs of life-saving cancer drugs.
Background
The Kerala High Court directed the National Cancer Institute (Jhajjar), Chittaranjan National Cancer Institute (Kolkata), Regional Cancer Centre (Thiruvananthapuram), and the Drug Controller General of India (DCGI) to submit reports by August 21. The legal action arose from a petition regarding the high cost of breast cancer medications.
Facts for Prelims
- BodyDCGI: Drug Controller General of India is the national regulatory authority for pharmaceuticals in India.
- PlaceChittaranjan National Cancer Institute is located in Kolkata.
- FactRibociclib and Palbociclib are drugs used in the treatment of specific types of breast cancer.
For Mains
Q. Discuss the challenges in ensuring the affordability of life-saving drugs in India and the role of judicial intervention in balancing patent rights with the right to health.
Dimensions to cover in your answer
- Regulatory bottleneck: Complexity in establishing bioequivalence for substituted drugs under current DCGI guidelines
- Patent vs. Access: Conflict between pharmaceutical intellectual property rights and the constitutional right to affordable healthcare
- Institutional coordination: Need for standardized clinical data sharing between national cancer institutes and regulatory bodies
Keywords: Right to Health · Bioequivalence · Affordability · Judicial Activism · Intellectual Property
More Social Justice notes
- Gujarat High Court: Scheduled Castes get lifetime reservation benefits, rejecting EPFO’s plea · 22 July 2026
- Karnataka FSDA Cracks Down: ₹28.91 Lakh Penalties for Trans Fat Violations · 22 July 2026
- Kerala Commission Rules Unaided School Staff Must Get Benefits Like Gratuities · 22 July 2026
- Bihar appoints 2,446 candidates in JEEViKA drive, aiming to empower over 30 lakh women · 22 July 2026
- Rajasthan's MAA Yojana Covers ₹17 Crore Treatments for 30,000 Patients Across India · 22 July 2026
- Uttar Pradesh to give free scooters to top 5% meritorious girl students · 22 July 2026
Something wrong, or something missing?
Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.
This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.